Testosteronologist® Mailbag 22

This mailbag discussion focuses on questions about laboratory concerns that arise during testosterone therapy. It explains why certain lab changes are expected and how monitoring helps differentiate adaptation from risk. Lab review is framed as a safety process rather than a trigger for immediate intervention.
A central portion discusses how markers such as hematocrit and hormone levels should be interpreted together over time. The episode emphasizes recognizing trends and context before making changes. Proportional interpretation is highlighted to avoid unnecessary disruption.
The closing segment reinforces laboratory monitoring as a core component of long-term testosterone management. Ongoing follow-up, documentation, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from steady oversight rather than reactive adjustment.